Wakefit Innovations Ltd Grants 4,57,611 Employee Stock Options under ESOP 2019
Wakefit Innovations Ltd has approved the grant of 4,57,611 employee stock options (ESOPs) as part of its WAKEFIT ESOP-2019 plan. The decision was made by the Nomination and Remuneration Committee (NRC) of the Board of Directors on July 13, 2026.The grant is defined under the provisions of the WAKEFIT ESOP-2019 scheme, with all related details provided in the company’s annexed documentation.
Key Terms and Financial Details
The approved stock options cover a total number of shares not exceeding 4,57,611 equity shares. These options were granted to employees under the plan. The exercise price for these options is determined at Re. 1/- per Option.A significant detail relating to the grant is that all vested Options must be exercised within a maximum period of one year from the date of vesting of the respective Options.
Vesting and Plan Conditions
The details surrounding the tenure and conditions of the stock options were also disclosed. The options are set to vest after a minimum period of 12 months from the Grant Date, provided this timeline does not exceed five years.Vesting is contingent upon employment status and will be determined according to the Letter of Grant, which may incorporate time and performance criteria. The company noted that vesting timelines for unauthorized or non-statutory leaves may be subject to extension as per the overall ESOP Plan. All other significant terms are governed by the Company's ESOP Plan.
WAKEFIT Stock Price Movement
Shares of Wakefit Innovations Limited are edging higher to ₹133.32 as of 1:17 PM today, having climbed by 2.71% in live trading. The equity has experienced active volatility throughout the day, trading between a low of ₹127.56 and a high of ₹137.45.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.